YBX1 and ovarian carcinoma: Remarkably, previous evidences point to YB-1 as an excellent molecular marker of ovarian cancer progression, as it has been found increased in experimental metastases in a murine model and a strong correlation was reported between high P-YB-1 levels in ovarian cancers and the poor outcome of patients [15, 45].